Table 4.
Linear regression analysis of the determination of impaired LV contractile function in overall cohort
| Circumferential PS | Longitudinal PS | |||
|---|---|---|---|---|
| Univariable β | Multivariable β | Univariable β | Multivariable β | |
| Age, per 10 units increase | 0.06 | 0.02 | ||
| Obesity#, yes or no | 0.18† | 0.20† | 0.20† | 0.12* |
| HT, yes or no | 0.04 | 0.22† | ||
| CAD, yes or no | 0.07 | 0.19† | 0.15† | |
| T2DM, yes or no | 0.12* | 0.10* | 0.34† | 0.18† |
| Insulin use, yes or no | 0.20† | 0.16† | 0.28† | 0.13* |
| NT-proBNP§, per 1 unit increase | 0.20† | 0.19† | 0.23† | 0.17† |
| eGFR, per 1 unit increase | -0.06 | -0.11* | ||
| Indexed LVM, per 1 unit increase | 0.20† | 0.16† | 0.26† | 0.18† |
β is adjusted regression coefficient
* P-value < 0.05. † P-value < 0.01
# Subjects with body mass index ≥ 25 kg/m2 were classified as obese group that proposed by the World Health Organization for Asian populations
§ NT-proBNP is log-transformed before being included in the regression analysis
Abbreviations: LV, left ventricular; PS, peak strain; HT, hypertension; CAD, coronary artery disease; DM, diabetes mellitus; NT-proBNP, amino-terminal pro-B-type natriuretic peptide; eGFR, estimated glomerular filtration rate; LVM, left ventricular mass